HEALTHCARE BIOTECH COUNCIL

Data & Digital

In political guidelines issued in July 2019, the European Commission prioritised working on a “Europe fit for the digital age.” In February 2020, the European Commission followed up on this priority, publishing its digital strategy titled “Shaping Europe’s Digital Future.”

EuropaBio is confident that the digitilisation of healthcare in Europe can help in the prevention, diagnosis, and the development of new diseases for conditions and healthcare challenges facing European society. For this reason, EuropaBio established a Digital Policy WG, whose purpose is to discuss how the digital revolution will affect healthcare, including how it can improve the R&D of new diagnostics and treatments for illnesses.

EuropaBio’s Digital Policy WG spearheads the Association’s work on all things digital – from developing the position on the biotech industry, to proactively creating policy recommendations, to thought leadership around how we can design and support policies that will enable the biotechnology sector to unlock the potential of digital technology to not only respond to, but to anticipate, society’s healthcare challenges.

  • Phytolon
  • Abolis
  • LithuaniaBIO
  • Health & Life Sciences cluster Bulgaria
  • EV Biotech
  • Olon Group
  • Remilk
  • Bon Vivant
  • Trinomab
  • Freget Glaser & Associes
  • The Union of Biotechnological Companies BioForum
  • SwiftPharma
  • Disc Medicine
  • Cytiva
  • 21st Bio
  • SwedenBIO
  • Ajinomoto Europe
  • Genopole
  • Alexion AstraZeneca Rare Disease
  • Bioeconomy for Change
  • Finnish BioIndustries
  • dsm-firmenich
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe

FOLLOW US HERE


Keep up with what is happening in the Biotech sector by connecting with us on social media!


 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe